D936Y and Other Mutations in the Fusion Core of the SARS-CoV-2 Spike Protein Heptad Repeat 1: Frequency, Geographical Distribution, and Structural Effect.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
30 Apr 2021
Historique:
received: 17 03 2021
revised: 08 04 2021
accepted: 12 04 2021
entrez: 5 5 2021
pubmed: 6 5 2021
medline: 14 5 2021
Statut: epublish

Résumé

The crown of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is constituted by its spike (S) glycoprotein. S protein mediates the SARS-CoV-2 entry into the host cells. The "fusion core" of the heptad repeat 1 (HR1) on S plays a crucial role in the virus infectivity, as it is part of a key membrane fusion architecture. While SARS-CoV-2 was becoming a global threat, scientists have been accumulating data on the virus at an impressive pace, both in terms of genomic sequences and of three-dimensional structures. On 15 February 2021, from the SARS-CoV-2 genomic sequences in the GISAID resource, we collected 415,673 complete S protein sequences and identified all the mutations occurring in the HR1 fusion core. This is a 21-residue segment, which, in the post-fusion conformation of the protein, gives many strong interactions with the heptad repeat 2, bringing viral and cellular membranes in proximity for fusion. We investigated the frequency and structural effect of novel mutations accumulated over time in such a crucial region for the virus infectivity. Three mutations were quite frequent, occurring in over 0.1% of the total sequences. These were S929T, D936Y, and S949F, all in the N-terminal half of the HR1 fusion core segment and particularly spread in Europe and USA. The most frequent of them, D936Y, was present in 17% of sequences from Finland and 12% of sequences from Sweden. In the post-fusion conformation of the unmutated S protein, D936 is involved in an inter-monomer salt bridge with R1185. We investigated the effect of the D936Y mutation on the pre-fusion and post-fusion state of the protein by using molecular dynamics, showing how it especially affects the latter one.

Identifiants

pubmed: 33946306
pii: molecules26092622
doi: 10.3390/molecules26092622
pmc: PMC8124767
pii:
doi:

Substances chimiques

Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Virol. 2020 Jul 1;94(14):
pubmed: 32376627
J Virol. 2015 Feb;89(4):1954-64
pubmed: 25428871
Nature. 2020 May;581(7807):221-224
pubmed: 32225175
J Mol Biol. 2001 Jan 19;305(3):535-57
pubmed: 11152611
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11727-11734
pubmed: 32376634
Glob Chall. 2017 Jan 10;1(1):33-46
pubmed: 31565258
Viruses. 2012 Apr;4(4):557-80
pubmed: 22590686
Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15214-9
pubmed: 25288733
Emerg Microbes Infect. 2020 Dec;9(1):382-385
pubmed: 32065055
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Cell Res. 2020 Apr;30(4):343-355
pubmed: 32231345
Molecules. 2015 Jul 01;20(7):12045-60
pubmed: 26140438
Cell Mol Immunol. 2020 Jun;17(6):621-630
pubmed: 32415260
Materials (Basel). 2020 Nov 26;13(23):
pubmed: 33255977
Nat Commun. 2020 May 4;11(1):2251
pubmed: 32366817
J Mol Biol. 1993 Dec 5;234(3):779-815
pubmed: 8254673
J Comput Chem. 2004 Mar;25(4):510-28
pubmed: 14735570
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
Nat Rev Microbiol. 2009 Mar;7(3):226-36
pubmed: 19198616
J Chem Theory Comput. 2015 Aug 11;11(8):3696-713
pubmed: 26574453
Proc Natl Acad Sci U S A. 2009 Apr 7;106(14):5871-6
pubmed: 19321428
Science. 2020 May 8;368(6491):630-633
pubmed: 32245784
Acta Crystallogr D Biol Crystallogr. 2002 Jun;58(Pt 6 No 1):899-907
pubmed: 12037327
Proc Natl Acad Sci U S A. 2017 Oct 17;114(42):11157-11162
pubmed: 29073020
J Transl Med. 2020 Jun 3;18(1):222
pubmed: 32493510
Euro Surveill. 2020 Aug;25(32):
pubmed: 32794443
Cell Res. 2013 Aug;23(8):986-93
pubmed: 23835475
Bioinformatics. 2011 Oct 15;27(20):2915-6
pubmed: 21873642
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Science. 2005 Sep 16;309(5742):1864-8
pubmed: 16166518
J Phys Chem B. 2014 Jun 19;118(24):6561-9
pubmed: 24702709
Proteins. 2013 Dec;81(12):2210-20
pubmed: 24115176
Science. 2020 Mar 27;367(6485):1444-1448
pubmed: 32132184
Cell. 2020 Sep 3;182(5):1284-1294.e9
pubmed: 32730807
Pharmacol Res. 2020 Jul;157:104859
pubmed: 32360480
Protein Sci. 2007 Sep;16(9):2030-41
pubmed: 17766392
J Chem Phys. 2007 Jan 7;126(1):014101
pubmed: 17212484
Nature. 2020 May;581(7807):215-220
pubmed: 32225176
Biochemistry. 1990 Mar 6;29(9):2403-8
pubmed: 2337607
BMC Bioinformatics. 2014;15 Suppl 5:S1
pubmed: 25077693
Cell Mol Immunol. 2020 Jul;17(7):765-767
pubmed: 32047258
Cell. 2020 May 14;181(4):894-904.e9
pubmed: 32275855
Immunity. 2020 Apr 14;52(4):583-589
pubmed: 32259480
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
Phys Chem Chem Phys. 2018 Jun 27;20(25):17020-17028
pubmed: 29904772

Auteurs

Romina Oliva (R)

Department of Sciences and Technologies, University Parthenope of Naples, Centro Direzionale Isola C4, I-80143 Naples, Italy.

Abdul Rajjak Shaikh (AR)

Kaust Catalysis Center, Physical Sciences and Engineering Division, King Abdullah University of Science and Technology (KAUST), Thuwal 23955-6900, Saudi Arabia.

Andrea Petta (A)

Dipartimento di Informatica ed Applicazioni, University of Salerno, Via Papa Paolo Giovanni II, I-84048 Fisciano, Italy.

Anna Vangone (A)

Roche Innovation Center Munich, Pharma Research and Early Development, Large Molecule Research, Nonnenwald 2, 82377 Penzberg, Germany.

Luigi Cavallo (L)

Kaust Catalysis Center, Physical Sciences and Engineering Division, King Abdullah University of Science and Technology (KAUST), Thuwal 23955-6900, Saudi Arabia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH